Wilko F.A.R. Verbakel

Dr. Wilko F.A.R. Verbakel


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
WVWilko Verbakel
Wilko Verbakel
SSSuresh Senan
Suresh Senan
JCJohan P. Cuijpers
Johan P. Cuijpers
BSBen J. Slotman
Ben J. Slotman
FLFrank Lagerwaard
Frank Lagerwaard

1 March 2020 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
PMPatricia van Marlen
Patricia van Marlen
MDMax Dahele
Max Dahele
MFMichael Folkerts
Michael Folkerts
EAEric Abel
Eric Abel
BSBerend J. Slotman
Berend J. Slotman
WVWilko Verbakel
Wilko Verbakel

1 July 2013 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
COChin Loon Ong
Chin Loon Ong
MDMax Dahele
Max Dahele
BSBen J. Slotman
Ben J. Slotman
WVWilko Verbakel
Wilko Verbakel

19 November 2015 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
JTJim P. Tol
Jim P. Tol
MDMax Dahele
Max Dahele
ADAlexander R. Delaney
Alexander R. Delaney
BSBen J. Slotman
Ben J. Slotman
WVWilko Verbakel
Wilko Verbakel
Treatment plan quality assurance (QA) is important for clinical studies and for institutions aiming to generate near-optimal individualized treatment plans. However, determining how good a given plan is for that particular patient (individualized patient/plan QA, in contrast to running through a checklist of generic QA parameters applied to all patients) is difficult, time consuming and operator-dependent. We therefore evaluated the potential of RapidPlan, a commercial knowledge-based planning solution, to automate this process, by predicting achievable OAR doses for individual patients based on a model library consisting of historical plans with a range of organ-at-risk (OAR) to planning target volume (PTV) geometries and dosimetries. A 90-plan RapidPlan model, generated using previously created automatic interactively optimized (AIO) plans, was used to predict achievable OAR dose-volume histograms (DVHs) for the parotid glands, submandibular glands, individual swallowing muscles and oral cavities of 20 head and neck cancer (HNC) patients using a volumetric modulated (RapidArc) simultaneous integrated boost technique. Predicted mean OAR doses were compared with mean doses achieved when RapidPlan was used to make a new plan. Differences between the achieved and predicted DVH-lines were analyzed. Finally, RapidPlan predictions were used to evaluate achieved OAR sparing of AIO and manual interactively optimized plans. For all OARs, strong linear correlations (R2 = 0.94–0.99) were found between predicted and achieved mean doses. RapidPlan generally overestimated the amount of achievable sparing for OARs with a large degree of OAR-PTV overlap. RapidPlan QA using predicted doses alone identified that for 50 % (10/20) of the manually optimized plans, sparing of the composite salivary glands, oral cavity or composite swallowing muscles could be improved by at least 3 Gy, 5 Gy or 7 Gy, respectively, while this was the case for 20 % (4/20) AIO plans. These predicted gains were validated by replanning the identified patients using RapidPlan. Strong correlations between predicted and achieved mean doses indicate that RapidPlan could accurately predict achievable mean doses. This shows the feasibility of using RapidPlan DVH prediction alone for automated individualized head and neck plan QA. This has applications in individual centers and clinical trials.

1 December 2020 in Radiotherapy and Oncology
Verified
Journal Article
Open access
CHChristian Rønn Hansen
Christian Rønn Hansen
WCWouter Crijns
Wouter Crijns
MHMohammad Hussein
Mohammad Hussein
LRLinda Rossi
Linda Rossi
PGPedro Gallego
Pedro Gallego
BHBen Heijmen
Ben Heijmen
Radiotherapy treatment planning studies contribute significantly to advances and improvements in radiation treatment of cancer patients. They are a pivotal step to support and facilitate the introduction of novel techniques into clinical practice, or as a first step before clinical trials can be carried out. There have been numerous examples published in the literature that demonstrated the feasibility of such techniques as IMRT, VMAT, IMPT, or that compared different treatment methods (e.g. non-coplanar vs coplanar treatment), or investigated planning approaches (e.g. automated planning). However, for a planning study to generate trustworthy new knowledge and give confidence in applying its findings, then its design, execution and reporting all need to meet high scientific standards. This paper provides a 'quality framework' of recommendations and guidelines that can contribute to the quality of planning studies and resulting publications. Throughout the text, questions are posed and, if applicable to a specific study and if met, they can be answered positively in the provided 'RATING' score sheet. A normalised weighted-sum score can then be calculated from the answers as a quality indicator. The score sheet can also be used to suggest how the quality might be improved, e.g. by focussing on questions with high weight, or by encouraging consideration of aspects given insufficient attention. Whilst the overall aim of this framework and scoring system is to improve the scientific quality of treatment planning studies and papers, it might also be used by reviewers and journal editors to help to evaluate scientific manuscripts reporting planning studies.

1 December 2010 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
WVWilko Verbakel
Wilko Verbakel
FLFrank Lagerwaard
Frank Lagerwaard
AVArjan J.E. Verduin
Arjan J.E. Verduin
SHStan Heukelom
Stan Heukelom
BSBen J. Slotman
Ben J. Slotman
JCJohan P. Cuijpers
Johan P. Cuijpers